Most Read Articles
28 Feb 2019
Arginine supplements appear to be an effective intervention for mild-to-moderate erectile dysfunction, a recent meta-analysis has shown.
03 Oct 2019
A short-term course of atorvastatin prior to radical prostatectomy does not yield significant benefits on the recovery of erectile function after the procedure, a recent study has found.
12 Dec 2018
Water vapour thermal therapy for lower urinary tract symptoms or benign prostatic hyperplasia does not negatively affect sexual function, a recent study has shown.
26 Oct 2019
Undergoing adjuvant radiotherapy after radical prostatectomy improves biochemical recurrence-free survival while being reasonably tolerable, a recent study has found.

Update on ADT: Degarelix shows promise in patients with advanced prostate cancer and CVD

26 Nov 2019
The incidence of prostate cancer (PC) and cardiovascular disease (CVD) typically increases with age; therefore, the choice of treatment for PC should take into account a patient’s underlying cardiovascular conditions. In this interview, Professor Laurence Klotz shared his take on androgen deprivation therapy (ADT) options for patients with prostate cancer who are at-risk of CV events.

Related MIMS Drugs

Editor's Recommendations
Most Read Articles
28 Feb 2019
Arginine supplements appear to be an effective intervention for mild-to-moderate erectile dysfunction, a recent meta-analysis has shown.
03 Oct 2019
A short-term course of atorvastatin prior to radical prostatectomy does not yield significant benefits on the recovery of erectile function after the procedure, a recent study has found.
12 Dec 2018
Water vapour thermal therapy for lower urinary tract symptoms or benign prostatic hyperplasia does not negatively affect sexual function, a recent study has shown.
26 Oct 2019
Undergoing adjuvant radiotherapy after radical prostatectomy improves biochemical recurrence-free survival while being reasonably tolerable, a recent study has found.